Lupin launches generic thyroid tablets in the US

Pharmaceutical major Lupin said that it has launched the generic equivalent of AbbVie Inc’s Synthroid tablets.

The Levothyroxine Sodium tablets is used to treat thyroid hormone deficiency, including the severe form known as myxedema coma. It is also used to treat and prevent certain types of thyroid tumors. It is taken by mouth or given by injection to a vein.

Levothyroxine sodium tablets had an annual sales of around $2.5 billion in the US market in doses ranging from 25 μg to 300 μg.

Lupin is one of the world’s biggest makers of generic drugs, and sells both branded and generic formulations, biotechnology products and pharmaceutical ingredients globally.

It is the world’s biggest manufacturer of anti-TB medicines and focuses on cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID segments of the pharma market.